RMTG Cellgenic unit begins commercial rollout in Colombia

• Regenerative Medical Technology Group’s Cellgenic division began local commercial activity in Colombia, marking its third recently announced Latin American market.
• Work includes establishing local representation, building relationships with physicians, operating only through permitted channels under Colombian requirements.
• Management flagged lead times for licensing, staffing, import logistics, physician onboarding.
• No revenue, physician-count, or demand guidance was provided; the update does not indicate product registration is complete.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regenerative Medical Technology Group Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202609080702ACCESSWRNAPR_____1217331) on September 08, 2026, and is solely responsible for the information contained therein.